These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 9607841)

  • 1. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.
    Anttila M; Eskola J; Ahman H; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1970-7. PubMed ID: 10217596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
    Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H
    Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.
    Dagan R; Melamed R; Zamir O; Leroy O
    Pediatr Infect Dis J; 1997 Nov; 16(11):1053-9. PubMed ID: 9384339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
    Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.
    Ahman H; Käyhty H; Lehtonen H; Leroy O; Froeschle J; Eskola J
    Pediatr Infect Dis J; 1998 Mar; 17(3):211-6. PubMed ID: 9535248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.
    Dagan R; Muallem M; Melamed R; Leroy O; Yagupsky P
    Pediatr Infect Dis J; 1997 Nov; 16(11):1060-4. PubMed ID: 9384340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.
    Nurkka A; Ahman H; Yaich M; Eskola J; Käyhty H
    Vaccine; 2001 Oct; 20(1-2):194-201. PubMed ID: 11567764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid.
    Ahman H; Käyhty H; Vuorela A; Leroy O; Eskola J
    Vaccine; 1999 Jun; 17(20-21):2726-32. PubMed ID: 10418924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children.
    Käyhty H; Ahman H; Rönnberg PR; Tillikainen R; Eskola J
    J Infect Dis; 1995 Nov; 172(5):1273-8. PubMed ID: 7594664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
    Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
    Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
    Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
    J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
    Nieminen T; Käyhty H; Leroy O; Eskola J
    Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.
    Vidarsson G; Sigurdardottir ST; Gudnason T; Kjartansson S; Kristinsson KG; Ingolfsdottir G; Jonsson S; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
    Infect Immun; 1998 Jun; 66(6):2866-70. PubMed ID: 9596761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
    Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
    Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
    Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.
    O'Brien KL; Steinhoff MC; Edwards K; Keyserling H; Thoms ML; Madore D
    Pediatr Infect Dis J; 1996 May; 15(5):425-30. PubMed ID: 8724065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
    Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
    Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.